Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GENEiQ is a private U.S. molecular diagnostics and pharmacogenomics company operating a clinical laboratory in the Dallas area. The company provides PCR-based infectious disease testing and pharmacogenomic testing intended to help clinicians identify pathogens, optimize medication selection, and support treatment decisions in settings such as long-term care, physician practices, and other healthcare organizations. Its offering appears centered on commercial laboratory services rather than a traditional therapeutic drug pipeline. Publicly available information describes the company as active and focused on urinary and respiratory pathogen testing alongside precision-medicine support tools for prescribers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GENEiQ.